Healthcare >> CEO Interviews >> November 17, 2008
RICHARD B. HOLLIS founded Hollis-Eden Pharmaceuticals, Inc., in August 1994, and
currently serves as Chairman, President and Chief Executive Officer. Mr. Hollis
has over 29 years' experience in the healthcare industry, has a proven track
record of launching and marketing important new medical products, and a
distinguished career of managing the growth and operations of companies in a
variety of senior management positions. Mr. Hollis began his career in product
sales with Baxter Travenol (today Baxter International), where he specialized in
launching and marketing parenteral, enteral and intravenous solutions to
hospitals and nursing homes. Mr. Hollis next joined Imed Corporation, a world
leader in drug delivery devices in the 1980s, where he rapidly advanced through
numerous sales, marketing and managerial positions. After leaving Warner
Lambert, Mr. Hollis joined Genentech, Inc., as the Bay Area biotechnology
revolution was unfolding. At Genentech, Mr. Hollis was instrumental in the
launch of two blockbuster pharmaceutical products-Protropin (human growth
hormone) and Activase (tissue plasiminogen activator). Profile
your scientific mission?
Mr. Hollis: The company was founded in 1994 and we went public in 1997. The
founding
